Cargando…
Drugs, genes and screens: The ethics of preventing and treating spinal muscular atrophy
Spinal muscular atrophy (SMA) is the most common genetic disease that causes infant mortality. Its treatment and prevention represent the paradigmatic example of the ethical dilemmas of 21st‐century medicine. New therapies (nusinersen and AVXS‐101) hold the promise of being able to treat, but not cu...
Autores principales: | Gyngell, Christopher, Stark, Zornitza, Savulescu, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318711/ https://www.ncbi.nlm.nih.gov/pubmed/31770817 http://dx.doi.org/10.1111/bioe.12695 |
Ejemplares similares
-
Intensive Care Clinicians’ Perspectives on Ethical Challenges Raised by Rapid Genomic Testing in Critically Ill Infants
por: Poogoda, Sachini, et al.
Publicado: (2023) -
The Ethics of Germline Gene Editing
por: Gyngell, Christopher, et al.
Publicado: (2016) -
Ethics of genomic passports: should the genetically resistant be exempted from lockdowns and quarantines?
por: Gyngell, Christopher, et al.
Publicado: (2022) -
Rapid Genomic Testing in Intensive Care: Health Professionals’ Perspectives on Ethical Challenges
por: Arkell, Katie, et al.
Publicado: (2023) -
Ethically utilising COVID-19 host-genomic data
por: Gyngell, Christopher, et al.
Publicado: (2021)